Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone

Michael J. Willhauck, Bibi Sharif-Samani, Reingard Senekowitsch-Schmidtke, Nathalie Wunderlich, Burkhard Göke, John C. Morris, Christine Spitzweg

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Context: The sodium iodide symporter (NIS) mediates iodide uptake in the thyroid gland as well as in lactating breast, and is also expressed in the majority of breast cancers. Recently, we have reported stimulation of all-trans retinoic acid (atRA)-induced NIS expression in the human breast cancer cell line MCF-7 by dexamethasone (Dex), resulting in an enhanced therapeutic effect of 131I in vitro. Objective: In the current study we examined the efficacy of Dex stimulation of atRA-induced NIS expression in vivo in MCF-7 xenotransplants in nude mice. After systemic treatment with atRA alone or in combination with Dex, iodide accumulation in the tumors was assessed by gamma camera imaging and gamma counter analysis. In addition, NIS expression was examined on RNA and protein level by RT-PCR and immunohistochemistry, respectively. Results: Using gamma camera imaging after intraperitoneal injection of 18.5 MBq 123I, no iodide accumulation was detected in tumors of untreated mice or mice treated with atRA only. After combined treatment with atRA/Dex significant 123I accumulation was detected in MCF-7 xenografts, which, by ex vivo gamma counting revealed a 3.3-fold increase in iodide accumulation as compared to control tumors. Surprisingly, in a subset of mice treated with atRA or atRA/Dex iodide accumulation was also detected in the normal mammary glands. In a normal human mammary epithelial cell line HB-2, however, no functional NIS expression was induced after treatment with atRA and/or Dex in vitro. Further, NIS mRNA and protein expression was detected in atRA/Dex treated MCF-7 tumors by RT-PCR and immunohistochemistry, respectively. Conclusion: Treatment with Dex in the presence of atRA is able to induce significant amounts of iodide accumulation in breast cancer xenotransplants in vivo due to stimulation of functional NIS protein expression, which opens exciting perspectives for a possible diagnostic and therapeutic role of radioiodine in the treatment of breast cancer.

Original languageEnglish (US)
Pages (from-to)263-272
Number of pages10
JournalBreast Cancer Research and Treatment
Volume109
Issue number2
DOIs
StatePublished - May 2008

Fingerprint

Tretinoin
Heterografts
Dexamethasone
Breast Neoplasms
Iodides
Therapeutics
Radionuclide Imaging
Neoplasms
Breast
Immunohistochemistry
sodium-iodide symporter
Cell Line
Polymerase Chain Reaction
Therapeutic Uses
Human Mammary Glands
Intraperitoneal Injections
Nude Mice
Thyroid Gland
Epithelial Cells
RNA

Keywords

  • Breast cancer
  • Dexamethasone
  • Radioiodine therapy
  • Retinoic acid
  • Sodium iodide symporter

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Willhauck, M. J., Sharif-Samani, B., Senekowitsch-Schmidtke, R., Wunderlich, N., Göke, B., Morris, J. C., & Spitzweg, C. (2008). Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Research and Treatment, 109(2), 263-272. https://doi.org/10.1007/s10549-007-9646-0

Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. / Willhauck, Michael J.; Sharif-Samani, Bibi; Senekowitsch-Schmidtke, Reingard; Wunderlich, Nathalie; Göke, Burkhard; Morris, John C.; Spitzweg, Christine.

In: Breast Cancer Research and Treatment, Vol. 109, No. 2, 05.2008, p. 263-272.

Research output: Contribution to journalArticle

Willhauck, MJ, Sharif-Samani, B, Senekowitsch-Schmidtke, R, Wunderlich, N, Göke, B, Morris, JC & Spitzweg, C 2008, 'Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone', Breast Cancer Research and Treatment, vol. 109, no. 2, pp. 263-272. https://doi.org/10.1007/s10549-007-9646-0
Willhauck, Michael J. ; Sharif-Samani, Bibi ; Senekowitsch-Schmidtke, Reingard ; Wunderlich, Nathalie ; Göke, Burkhard ; Morris, John C. ; Spitzweg, Christine. / Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. In: Breast Cancer Research and Treatment. 2008 ; Vol. 109, No. 2. pp. 263-272.
@article{6cdfd75b54e14a7a8a37e93c1c851b99,
title = "Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone",
abstract = "Context: The sodium iodide symporter (NIS) mediates iodide uptake in the thyroid gland as well as in lactating breast, and is also expressed in the majority of breast cancers. Recently, we have reported stimulation of all-trans retinoic acid (atRA)-induced NIS expression in the human breast cancer cell line MCF-7 by dexamethasone (Dex), resulting in an enhanced therapeutic effect of 131I in vitro. Objective: In the current study we examined the efficacy of Dex stimulation of atRA-induced NIS expression in vivo in MCF-7 xenotransplants in nude mice. After systemic treatment with atRA alone or in combination with Dex, iodide accumulation in the tumors was assessed by gamma camera imaging and gamma counter analysis. In addition, NIS expression was examined on RNA and protein level by RT-PCR and immunohistochemistry, respectively. Results: Using gamma camera imaging after intraperitoneal injection of 18.5 MBq 123I, no iodide accumulation was detected in tumors of untreated mice or mice treated with atRA only. After combined treatment with atRA/Dex significant 123I accumulation was detected in MCF-7 xenografts, which, by ex vivo gamma counting revealed a 3.3-fold increase in iodide accumulation as compared to control tumors. Surprisingly, in a subset of mice treated with atRA or atRA/Dex iodide accumulation was also detected in the normal mammary glands. In a normal human mammary epithelial cell line HB-2, however, no functional NIS expression was induced after treatment with atRA and/or Dex in vitro. Further, NIS mRNA and protein expression was detected in atRA/Dex treated MCF-7 tumors by RT-PCR and immunohistochemistry, respectively. Conclusion: Treatment with Dex in the presence of atRA is able to induce significant amounts of iodide accumulation in breast cancer xenotransplants in vivo due to stimulation of functional NIS protein expression, which opens exciting perspectives for a possible diagnostic and therapeutic role of radioiodine in the treatment of breast cancer.",
keywords = "Breast cancer, Dexamethasone, Radioiodine therapy, Retinoic acid, Sodium iodide symporter",
author = "Willhauck, {Michael J.} and Bibi Sharif-Samani and Reingard Senekowitsch-Schmidtke and Nathalie Wunderlich and Burkhard G{\"o}ke and Morris, {John C.} and Christine Spitzweg",
year = "2008",
month = "5",
doi = "10.1007/s10549-007-9646-0",
language = "English (US)",
volume = "109",
pages = "263--272",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone

AU - Willhauck, Michael J.

AU - Sharif-Samani, Bibi

AU - Senekowitsch-Schmidtke, Reingard

AU - Wunderlich, Nathalie

AU - Göke, Burkhard

AU - Morris, John C.

AU - Spitzweg, Christine

PY - 2008/5

Y1 - 2008/5

N2 - Context: The sodium iodide symporter (NIS) mediates iodide uptake in the thyroid gland as well as in lactating breast, and is also expressed in the majority of breast cancers. Recently, we have reported stimulation of all-trans retinoic acid (atRA)-induced NIS expression in the human breast cancer cell line MCF-7 by dexamethasone (Dex), resulting in an enhanced therapeutic effect of 131I in vitro. Objective: In the current study we examined the efficacy of Dex stimulation of atRA-induced NIS expression in vivo in MCF-7 xenotransplants in nude mice. After systemic treatment with atRA alone or in combination with Dex, iodide accumulation in the tumors was assessed by gamma camera imaging and gamma counter analysis. In addition, NIS expression was examined on RNA and protein level by RT-PCR and immunohistochemistry, respectively. Results: Using gamma camera imaging after intraperitoneal injection of 18.5 MBq 123I, no iodide accumulation was detected in tumors of untreated mice or mice treated with atRA only. After combined treatment with atRA/Dex significant 123I accumulation was detected in MCF-7 xenografts, which, by ex vivo gamma counting revealed a 3.3-fold increase in iodide accumulation as compared to control tumors. Surprisingly, in a subset of mice treated with atRA or atRA/Dex iodide accumulation was also detected in the normal mammary glands. In a normal human mammary epithelial cell line HB-2, however, no functional NIS expression was induced after treatment with atRA and/or Dex in vitro. Further, NIS mRNA and protein expression was detected in atRA/Dex treated MCF-7 tumors by RT-PCR and immunohistochemistry, respectively. Conclusion: Treatment with Dex in the presence of atRA is able to induce significant amounts of iodide accumulation in breast cancer xenotransplants in vivo due to stimulation of functional NIS protein expression, which opens exciting perspectives for a possible diagnostic and therapeutic role of radioiodine in the treatment of breast cancer.

AB - Context: The sodium iodide symporter (NIS) mediates iodide uptake in the thyroid gland as well as in lactating breast, and is also expressed in the majority of breast cancers. Recently, we have reported stimulation of all-trans retinoic acid (atRA)-induced NIS expression in the human breast cancer cell line MCF-7 by dexamethasone (Dex), resulting in an enhanced therapeutic effect of 131I in vitro. Objective: In the current study we examined the efficacy of Dex stimulation of atRA-induced NIS expression in vivo in MCF-7 xenotransplants in nude mice. After systemic treatment with atRA alone or in combination with Dex, iodide accumulation in the tumors was assessed by gamma camera imaging and gamma counter analysis. In addition, NIS expression was examined on RNA and protein level by RT-PCR and immunohistochemistry, respectively. Results: Using gamma camera imaging after intraperitoneal injection of 18.5 MBq 123I, no iodide accumulation was detected in tumors of untreated mice or mice treated with atRA only. After combined treatment with atRA/Dex significant 123I accumulation was detected in MCF-7 xenografts, which, by ex vivo gamma counting revealed a 3.3-fold increase in iodide accumulation as compared to control tumors. Surprisingly, in a subset of mice treated with atRA or atRA/Dex iodide accumulation was also detected in the normal mammary glands. In a normal human mammary epithelial cell line HB-2, however, no functional NIS expression was induced after treatment with atRA and/or Dex in vitro. Further, NIS mRNA and protein expression was detected in atRA/Dex treated MCF-7 tumors by RT-PCR and immunohistochemistry, respectively. Conclusion: Treatment with Dex in the presence of atRA is able to induce significant amounts of iodide accumulation in breast cancer xenotransplants in vivo due to stimulation of functional NIS protein expression, which opens exciting perspectives for a possible diagnostic and therapeutic role of radioiodine in the treatment of breast cancer.

KW - Breast cancer

KW - Dexamethasone

KW - Radioiodine therapy

KW - Retinoic acid

KW - Sodium iodide symporter

UR - http://www.scopus.com/inward/record.url?scp=43149109505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43149109505&partnerID=8YFLogxK

U2 - 10.1007/s10549-007-9646-0

DO - 10.1007/s10549-007-9646-0

M3 - Article

VL - 109

SP - 263

EP - 272

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -